National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 15729 [2023-05151]
Download as PDF
<![CDATA[
15729
Federal Register / Vol. 88, No. 49 / Tuesday, March 14, 2023 / Notices
Authority: 42 U.S.C. 1313, 24 U.S.C.
321–329.
John M. Sweet, Jr,
ACF/OPRE Certifying Officer.
[FR Doc. 2023–05196 Filed 3–13–23; 8:45 am]
BILLING CODE 4184–PL–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0937–new]
Agency Information Collection
Request; 60-Day Public Comment
Request
AGENCY:
ACTION:
Office of the Secretary, HHS.
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
SUMMARY:
Comments on the ICR must be
received on or before May 15, 2023.
DATES:
Number of
respondents
Type of Collection: new.
OMB No.: 0937–New–60D.
Abstract: The Office of Population
Affairs (OPA), in the Office of the
Assistant Secretary for Health (OASH),
U.S. Department of Health and Human
Services (HHS), requests a new
clearance for the collection of
performance measures specifically for
new FY2023 Teen Pregnancy Prevention
(TPP) Program grantees. In FY2023,
OPA expects to award 5-year TPP
cooperative agreements to up to 96
organizations across three Notice of
Funding Opportunities (NOFOs).
Collection of performance measures is a
requirement of all TPP awards and is
included in the NOFOs. The data
collection will allow OPA to comply
with federal accountability and
performance requirements, inform
stakeholders of grantee progress in
meeting TPP program goals, provide
OPA with metrics for monitoring
FY2023 TPP grantees, and facilitate
individual grantees’ continuous quality
improvement efforts within their
projects. OPA requests clearance for
three years.
Annualized Burden Hour Table:
Number of
responses per
respondents
Average
burden per
response
Total
burden
hours
Forms (if necessary)
Respondents (if necessary)
TPP Tier 1 & Tier 2 Rigorous Impact
grantees.
Supportive Services ..........................
Tier 2 Innovation Network .................
TPP Tier 1 & Tier 2 Rigorous Impact grantees.
Tier 1 Grantees ................................
Tier 2 Innovation Network Grantees
86
2
8
1376
70
10
2
2
15/60
1
35
20
Total ...........................................
...........................................................
........................
18
........................
1431
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2023–05158 Filed 3–13–23; 8:45 am]
BILLING CODE 4150–11–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 264–0041 and PRA@HHS.GOV.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0937–New–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, PRA@
HHS.GOV or call (202) 264–0041 the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Teen
Pregnancy Prevention FY2023
performance measures collection.
ADDRESSES:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
21:09 Mar 13, 2023
Jkt 259001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Translational and Brain
Devices Panel.
Date: March 16, 2023.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892,
301–435–6033, rajarams@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
PO 00000
Frm 00091
Fmt 4703
Sfmt 9990
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: March 8, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–05151 Filed 3–13–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\14MRN1.SGM
14MRN1
]]>Agencies
[Federal Register Volume 88, Number 49 (Tuesday, March 14, 2023)]
[Notices]
[Page 15729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05151]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Translational and Brain Devices
Panel.
Date: March 16, 2023.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Shanta Rajaram, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC
9529, Bethesda, MD 20892, 301-435-6033, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
Dated: March 8, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-05151 Filed 3-13-23; 8:45 am]
BILLING CODE 4140-01-P
